Splicing factor Tra2-β1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene

Cancer Research

Volumn 66, Issue 9, 2006, Pages 4774-4780

  Watermann, Dirk O ^a   Tang, Yesheng ^b   Hausen, Axel Zur ^a   Jäger, Markus ^b   Stamm, Stefan ^b   Stickeler, Elmar ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN ISOLATION; RNA SPLICING; TUMOR GROWTH;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BASE SEQUENCE; BREAST NEOPLASMS; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; TRANSFECTION; UP-REGULATION;

EID: 33646426385     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3294     Document Type: Article

References (53)

1. Smith CW, Valcarcel J. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 2000;25:381-8.
2. Black DL. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 2000;103:367-70.
3. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2000;72:291-336.
4. Johnson JM, Castle J, Garrett-Engele P, et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302:2141-4.
5. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003;17:419-37.
6. Stoilov P, Meshorer E, Gencheva M, et al. Defects in pre-mRNA processing as causes of and predisposition to diseases. DNA Cell Biol 2002;21:803-18.
7. Lukas J, Gao DQ, Keshmeshian M, et al. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 2001;61: 3212-9.
8. Ge K, Minhas F, Duhadaway J, et al. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000;86:155-6.
9. Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M. Alternative splicing of fibroblast growth factor receptors in human prostate cancer. Prostate 2001;46:163-72.
10. Xu K, Wang X, Ling MT, et al. Identification of a specifically expressed modified form of novel PSP-94 protein in the secretion of benign prostatic hyperplasia. Electrophoresis 2003;24:1311-8.
11. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 184:47-63.
12. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992;89:12160-4.
13. Ponta H, Wainwright D, Herrlich P. The CD44 protein family. Int J Biochem Cell Biol 1998;30:299-305.
14. Helliwell TR. Molecular markers of metastasis in squamous carcinomas. J Pathol 2001;194:289-93.
15. Wielenga VJ, van der Neut R, Offerhaus GJ, Pals ST. CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv Cancer Res 2000;77: 169-87.
16. Stickeler E, Kittrell F, Medina D, Berget SM. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999;18: 3574-82.
17. Konig H, Ponta H, Herrlich P. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J 1998;17:2904-13.
18. Matter N, Marx M, Weg-Remers S, et al. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J Biol Chem 2000;275:35353-60.
19. Matter N, Herrlich P, Konig H. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 2002;420:691-5.
20. van Oers CC, Adema GJ, Zandberg H, Moen TC, Baas PD. Two different sequence elements within exon 4 are necessary for calcitonin-specific splicing of the human calcitonin/calcitonin gene-related peptide I pre-mRNA. Mol Cell Biol 1994;14:951-60.
21. Wang Z, Hoffmann HM, Grabowski PJ. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1995; 1:21-35.
22. Coulter LR, Landree MA, Cooper TA. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol Cell Biol 1997;17:2143-50.
23. Schaal TD, Maniatis T. Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol Cell Biol 1999;19: 261-73.
24. Stickeler E, Fraser SD, Honig A, et al. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J 2001;20:3821-30.
25. Hedley ML, Maniatis T. Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro. Cell 1991; 65:579-86.
26. Inoue K, Hoshijima K, Higuchi I, Sakamoto H, Shimura Y. Binding of the Drosophila transformer and transformer-2 proteins to the regulatory elements of doublesex primary transcript for sex-specific RNA processing. Proc Natl Acad Sci U S A 1992;89:8092-6.
27. Tian M, Maniatis T. Positive control of pre-mRNA splicing in vitro. Science 1992;256:237-40.
28. Tian M, Maniatis T. A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev 1994;8: 1703-12.
29. Heinrichs V, Baker BS. The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J 1995;14:3987-4000.
30. Lynch KW, Maniatis T. Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev 1995;9:284-93.
31. Lynch KW, Maniatis T. Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev 1996;10:2089-101.
32. Dauwalder B, Amaya-Manzanares F, Mattox W. A human homologue of the Drosophila sex determination factor transformer-2 has conserved splicing regulatory functions. Proc Natl Acad Sci U S A 1996;93:9004-9.
33. Beil B, Screaton G, Stamm S. Molecular cloning of htra2-β-1 and htra2-β-2. two human homologs of tra-2 generated by alternative splicing. DNA Cell Biol 1997; 16:679-90.
34. Tacke R, Tohyama M, Ogawa S, Manley JL. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 1998;93:139-48.
35. Jiang Z, Tang H, Havlioglu N, et al. Mutations in τ gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 β. J Biol Chem 2003;278:18997-9007.
36. Stamm S, Casper D, Hanson V, Helfman DM. Regulation of the neuron-specific exon of clathrin light chain B. Brain Res Mol Brain Res 1999;4:108-18.
37. Stoilov P, Daoud R, Nayler O, Stamm S. Human tra2-1 autoregulates its protein concentration by binding to novel exonic enhancers of its exon 2. Hum Mol Genet 2004;13:509-24.
38. Daoud R, Mies G, Smialowska A, et al. Ischemia induces a translocation of the splicing factor tra2-β1 and changes alternative splicing patterns in the brain. J Neurosci 2002;22:5889-99.
39. Matsuo N, Ogawa S, Imai Y, et al. Cloning of a novel RNA binding polypeptide (RA301) induced by hypoxia/ reoxygenation. J Biol Chem 1995;270:28216-22.
40. Tsukamoto Y, Matsuo N, Ozawa K, et al. Expression of a novel RNA-splicing factor, RA301/Tra2β, in vascular lesions and its role in smooth muscle cell proliferation. Am J Pathol 2001;158:1685-94.
41. Kiryu-Seo S, Matsuo N, Wanaka A, et al. A sequence-specific splicing activator, tra2β, is up-regulated in response to nerve injury. Brain Res Mol Brain Res 1998; 62:220-3.
42. Segade F, Claudio E, Wrobel K, Ramos S, Lazo PS. Isolation of nine gene sequences induced by silica in murine macrophages. J Immunol 1995;154:2384-92.
43. Daoud R, Da Penha Berzaghi M, Siedler F, Hubener M, Stamm S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur J Neurosci 1999;11:788-802.
44. Honig A, Auboeuf D, Parker MM, O'Malley BW. Berget SM. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72. Mol Cell Biol 2002;22:5698-707.
45. Dominski Z, Kole R. Cooperation of pre-mRNA sequence elements in splice site selection. Mol Cell Biol 1992;12:2108-14.
46. Burtis KC. The regulation of sex determination and sexually dimorphic differentiation in Drosophila. Curr Opin Cell Biol 1993;5:1006-14.
47. Stickeler E, Mobus VJ, Kieback DG, et al. Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer. Anticancer Res 1997;17:4395-8.
48. Stickeler E, Runnebaum IB, Mobus VJ, Kieback DG, Kreienberg R Expression of CD44 standard and variant isoforms v5, v6, and v7 in human ovarian cancer cell lines. Anticancer Res 1997;17: 1871-6.
49. Hofmann Y, Wirth B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-1. Hum Mol Genet 2002;11: 2037-49.
50. Nasim MT, Chernova TK, Chowdhury HM, Yue BG, Eperon IC. HnRNP G and Tra2β: opposite effects on splicing matched by antagonism in RNA binding. Hum Mol Genet 2003;12:1337-48.
51. Ferro P, Forlani A, Muselli M, Pfeffer U. Alternative splicing of the human estrogen receptor ot primary transcript: mechanisms of exon skipping. Int J Mol Med 2003;12:355-63.
52. Mercatante DR, Bortner CD, Cidlowski JA, Kole R. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. Analysis of apoptosis and cell death. J Biol Chem 2001;276: 16411-7.
53. Orban TI, Olah E. Emerging roles of BRCA1 alternative splicing. Mol Pathol 2003;56:191-7.